growing coin, searches

Japan Life Insurance announced that it would spend $8.2 billion to acquire the life insurance company Resolution Life. On December 11th, Japan Life Insurance Mutual announced that it would spend about $8.2 billion to acquire the remaining 77% shares of the life insurance company Resolution Life. The transaction is expected to be completed in the second half of 2025. On the same day, Japan Life announced that it would acquire the remaining 20% shares of MLC Life Insurance from National Bank of Australia (NAB) and integrate MLC with Resolution Life.A court in Hong Kong dismissed the liquidation case against Territorial Holdings, and a court in Hong Kong dismissed the liquidation case after the petition against Territorial Holdings, a real estate developer in China, was revoked. Our headquarters finance group withdrew the petition, and the debts and expenses have been settled. The liquidation petition was filed in September, involving an outstanding sum of HK$ 275,633.29. (Interface News)According to Tesla, from December 2 to December 8, Tesla sold 21,900 units in China, the highest weekly sales since the fourth quarter of this year. Up to now, Model Y has sold more than 556,000 vehicles.

On the analysis of the daily limit at noon on December 11th, the three major indexes rose slightly, and consumer electronics concept stocks broke out collectively. Yiming food has 12 boards, Shandong glass fiber has 6 boards, one picture can be understood > >Trader: The Indian central bank is suspected of selling dollars to limit the depreciation of Indian Rupee.Jinling Pharmaceutical Co., Ltd.: Magnesium sulfate injection has obtained the drug registration certificate. Jinling Pharmaceutical Co., Ltd. announced that Nanjing Jinling Pharmaceutical Factory, a subsidiary of the company, recently received the "Drug Registration Certificate" for magnesium sulfate injection issued by National Medical Products Administration. Magnesium sulfate injection can be used for the treatment of pregnancy-induced hypertension, eclampsia and preeclampsia, and plays an important role in the prevention and treatment of many diseases. The drug has been recommended by related guides in China, the United States and Canada. This drug registration is conducive to the company's future market expansion and sales, but the production and sales of drugs may be affected by changes in policies and market environment, which is uncertain.

Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.Japan's auto trade unions have raised their salary increase targets for the first time in seven years. On Wednesday, the trade unions of major Japanese automakers said that they would seek a monthly salary increase of 12,000 yen (US$ 79.15) or more in next year's spring wage negotiations. This is the first time in seven years that the Japan Automobile Trade Union Federation has put forward the specific goal of labor-capital negotiation. At a news conference, the organization's executives said that the organization decided to resume its actual goal in order to provide guidance for smaller trade unions such as component manufacturers in negotiations. The organization has 12 trade unions, including Toyota Motor Union, with a total of 784,000 employees. According to the report, Rengo, Japan's largest trade union organization with auto trade unions, is seeking to raise wages by at least 5% in 2025, similar to this year's substantial increase.Does the United States or cancel the recognition of the "Sham Liberation Organization" terrorist organization? US officials responded that according to media reports such as CNN, John Kirby, strategic communication coordinator of the US White House National Security Council, said on the 10th local time that the United States has not seriously discussed the cancellation of the Syrian opposition "Sharm Liberation Organization" (HTS) terrorist organization identification. Earlier, some media quoted an anonymous senior official of the US government as saying that the US government did not rule out removing HTS from the list of terrorist organizations recognized by the United States in order to establish closer ties with it. (World Wide Web)